{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:10:42Z","timestamp":1792098642668,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Studies have suggested that patients with inflammatory bowel disease (IBD) have an increased risk of rheumatoid arthritis (RA). However, the available data on this association are inconsistent. This meta-analysis aimed to determine the association between IBD and the risk of RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Observational studies investigating the RA risk among patients with IBD (Crohn disease (CD) and\/or ulcerative colitis (UC)) were searched in PubMed, Embase, and Web of Science from the date of inception to December 2019. The methodological quality of the included studies was assessed using the Newcastle-Ottawa Scale. Relative risks (RRs) and corresponding 95% confidential intervals (CIs) were pooled with a random-effects model. Heterogeneity was evaluated using I\n                      <jats:sup>2<\/jats:sup>\n                      statistics while publication bias was determined using Begg\u2019s and Egger\u2019s tests. Subgroup and sensitivity analyses were performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of three cohort studies, three cross-sectional studies, and two case-control studies were included in the meta-analyses. Compared to the non-IBD control or general population, there was a significantly higher risk of RA among patients with IBD (RR\u2009=\u20092.59; 95% CI: 1.93\u20133.48). Moreover, both CD (RR\u2009=\u20093.14; 95% CI: 2.46\u20134.01) and UC (RR\u2009=\u20092.29; 95% CI: 1.76\u20132.97) were associated with a significantly increased risk of RA. However, heterogeneity was substantial across studies and the subgroup analyses failed to identify the potential source of heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with IBD have a greater risk of developing RA. Rheumatologists should be consulted when patients with IBD present with undifferentiated joint complaints. However, more prospective cohort studies are needed to validate these results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-020-01339-3","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T09:03:53Z","timestamp":1592384633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsheng","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangtong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5467-2927","authenticated-orcid":false,"given":"Huixiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"issue":"9573","key":"1339_CR1","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369(9573):1641\u201357.","journal-title":"Lancet"},{"issue":"10","key":"1339_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrgastro.2013.117","volume":"10","author":"C Ott","year":"2013","unstructured":"Ott C, Scholmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10(10):585\u201395.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"1339_CR3","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1148\/rg.2017160121","volume":"37","author":"JD Olpin","year":"2017","unstructured":"Olpin JD, Sjoberg BP, Stilwill SE, Jensen LE, Rezvani M, Shaaban AM. Beyond the bowel: Extraintestinal manifestations of inflammatory bowel disease. Radiographics. 2017;37(4):1135\u201360.","journal-title":"Radiographics"},{"issue":"3","key":"1339_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","volume":"10","author":"M Harbord","year":"2016","unstructured":"Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10(3):239\u201354.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"1339_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/gut.42.3.387","volume":"42","author":"TR Orchard","year":"1998","unstructured":"Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut. 1998;42(3):387\u201391.","journal-title":"Gut"},{"issue":"7 Suppl","key":"1339_CR6","first-page":"S128","volume":"20","author":"A Gibofsky","year":"2014","unstructured":"Gibofsky A. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis. Am J Manag Care. 2014;20(7 Suppl):S128\u201335.","journal-title":"Am J Manag Care"},{"issue":"10086","key":"1339_CR7","first-page":"2328","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet Gastroenterol Hepatol. 2017;389(10086):2328\u201337.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"1339_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S2468-1253(19)30173-6","volume":"4","author":"M Argollo","year":"2019","unstructured":"Argollo M, Gilardi D, Peyrin-Biroulet C, Chabot JF, Peyrin-Biroulet L, Danese S. Comorbidities in inflammatory bowel disease: a call for action. Lancet Gastroenterol Hepatol. 2019;4(8):643\u201354.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"1339_CR9","doi-asserted-by":"publisher","first-page":"e0200363","DOI":"10.1371\/journal.pone.0200363","volume":"13","author":"BR Yang","year":"2018","unstructured":"Yang BR, Choi NK, Kim MS, Chun J, Joo SH, Kim H, et al. Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients. PLoS One. 2018;13(7):e0200363.","journal-title":"PLoS One"},{"issue":"7","key":"1339_CR10","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/j.1572-0241.2007.01215.x","volume":"102","author":"X Weng","year":"2007","unstructured":"Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern California-managed care organization. Am J Gastroenterol. 2007;102(7):1429\u201335.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"1339_CR11","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/archdischild-2011-300633","volume":"96","author":"MD Kappelman","year":"2011","unstructured":"Kappelman MD, Galanko JA, Porter CQ, Sandler RS. Association of paediatric inflammatory bowel disease with other immune-mediated diseases. Arch Dis Child. 2011;96(11):1042\u20136.","journal-title":"Arch Dis Child"},{"issue":"33","key":"1339_CR12","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","volume":"23","author":"ML Halling","year":"2017","unstructured":"Halling ML, Kjeldsen J, Knudsen T, Nielsen J, Hansen LK. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J Gastroenterol. 2017;23(33):6137\u201346.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"1339_CR13","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/ibd.20406","volume":"14","author":"R Cohen","year":"2008","unstructured":"Cohen R, Robinson D Jr, Paramore C, Fraeman K, Renahan K, Bala M. Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002. Inflamm Bowel Dis. 2008;14(6):738\u201343.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"1339_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/14397595.2016.1211229","volume":"27","author":"JM Bae","year":"2017","unstructured":"Bae JM, Choo JY, Kim KJ, Park KS. Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: a nationwide population-based study. Mod Rheumatol. 2017;27(3):435\u201340.","journal-title":"Mod Rheumatol"},{"issue":"2","key":"1339_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/apt.15076","volume":"49","author":"SW Park","year":"2019","unstructured":"Park SW, Kim TJ, Lee JY, Kim ER, Hong SN, Chang DK, et al. Comorbid immune-mediated diseases in inflammatory bowel disease: a nation-wide population-based study. Aliment Pharmacol Ther. 2019;49(2):165\u201372.","journal-title":"Aliment Pharmacol Ther"},{"issue":"13","key":"1339_CR16","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1016\/j.cgh.2019.03.040","volume":"17","author":"J Burisch","year":"2019","unstructured":"Burisch J, Jess T, Egeberg A. Incidence of immune-mediated inflammatory diseases among patients with inflammatory bowel diseases in Denmark. Clin Gastroenterol Hepatol. 2019;17(13):2704\u201312.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"1339_CR17","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1007\/s12325-019-00964-z","volume":"36","author":"D Aletaha","year":"2019","unstructured":"Aletaha D, Epstein AJ, Skup M, Zueger P, Garg V, Panaccione R. Risk of developing additional immune-mediated manifestations: a retrospective matched cohort study. Adv Ther. 2019;36(7):1672\u201383.","journal-title":"Adv Ther"},{"issue":"12","key":"1339_CR18","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1016\/j.mayocp.2019.08.010","volume":"94","author":"VL Kronzer","year":"2019","unstructured":"Kronzer VL, Crowson CS, Sparks JA, Myasoedova E, Davis JM 3rd. Comorbidities as risk factors for rheumatoid arthritis and their accrual after diagnosis. Mayo Clin Proc. 2019;94(12):2488\u201398.","journal-title":"Mayo Clin Proc"},{"key":"1339_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/annrheumdis-2014-eular.5122","volume":"73","author":"K Puolakka","year":"2014","unstructured":"Puolakka K, Rantalaiho V, Kautiainen H, Farkkila M. The concomitance of inflammatory bowel disease with incident rheumatoid arthritis and ankylosing spondylitis in Finland [Abstract]. Ann Rheum Dis. 2014;73:403\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1339_CR20","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006\u201312.","journal-title":"J Clin Epidemiol"},{"issue":"15","key":"1339_CR21","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008\u201312.","journal-title":"JAMA"},{"key":"1339_CR22","unstructured":"Wells GA, Shea D, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. ohri.ca http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 25 Jul 2019."},{"key":"1339_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1471-2458-13-154","volume":"13","author":"R Herzog","year":"2013","unstructured":"Herzog R, Alvarez-Pasquin MJ, Diaz C, Del Barrio JL, Estrada JM, Gil A. Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health. 2013;13:154.","journal-title":"BMC Public Health"},{"key":"1339_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/oxfordjournals.epirev.a036298","volume":"9","author":"S Greenland","year":"1987","unstructured":"Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiologic Rev. 1987;9:1\u201330.","journal-title":"Epidemiologic Rev"},{"issue":"3","key":"1339_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"7109","key":"1339_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"4","key":"1339_CR27","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088\u2013101.","journal-title":"Biometrics"},{"issue":"4","key":"1339_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/1751-2980.12229","volume":"16","author":"KH Chua","year":"2015","unstructured":"Chua KH, Lian LH, Khor WC, Lee WS, Hilmi I, Goh KL, et al. Association between genetic polymorphisms in interferon regulatory factor 5 (IRF5) gene and Malaysian patients with Crohn's disease. J Dig Dis. 2015;16(4):205\u201316.","journal-title":"J Dig Dis"},{"issue":"10","key":"1339_CR29","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3109\/00365521.2013.828775","volume":"48","author":"P Li","year":"2013","unstructured":"Li P, Lv H, Yang H, Qian JM. IRF5, but not TLR4, DEFB1, or VDR, is associated with the risk of ulcerative colitis in a Han Chinese population. Scand J Gastroenterol. 2013;48(10):1145\u201351.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"1339_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/ard.2010.129171","volume":"70","author":"K Dawidowicz","year":"2011","unstructured":"Dawidowicz K, Allanore Y, Guedj M, Pierlot C, Bombardieri S, Balsa A, et al. The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype. Ann Rheum Dis. 2011;70(1):117\u201321.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1339_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/gut.2008.166918","volume":"58","author":"EA Festen","year":"2009","unstructured":"Festen EA, Goyette P, Scott R, Annese V, Zhernakova A, Lian J, et al. Genetic variants in the region harbouring IL2\/IL21 associated with ulcerative colitis. Gut. 2009;58(6):799\u2013804.","journal-title":"Gut"},{"issue":"6","key":"1339_CR32","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1086\/522037","volume":"81","author":"A Zhernakova","year":"2007","unstructured":"Zhernakova A, Alizadeh BZ, Bevova M, van Leeuwen MA, Coenen MJ, Franke B, et al. Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet. 2007;81(6):1284\u20138.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1339_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/MIB.0000000000000584","volume":"22","author":"BD Ye","year":"2016","unstructured":"Ye BD, Choi H, Hong M, Yun WJ, Low HQ, Haritunians T, et al. Identification of ten additional susceptibility loci for ulcerative colitis through Immunochip analysis in Koreans. Inflamm Bowel Dis. 2016;22(1):13\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"1339_CR34","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/ng.233","volume":"40","author":"S Raychaudhuri","year":"2008","unstructured":"Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP, et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet. 2008;40(10):1216\u201323.","journal-title":"Nat Genet"},{"issue":"8","key":"1339_CR35","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ng.175","volume":"40","author":"JC Barrett","year":"2008","unstructured":"Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008;40(8):955\u201362.","journal-title":"Nat Genet"},{"issue":"6","key":"1339_CR36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/ng.582","volume":"42","author":"EA Stahl","year":"2010","unstructured":"Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010;42(6):508\u201314.","journal-title":"Nat Genet"},{"key":"1339_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.biocel.2018.03.012","volume":"99","author":"TE Khoyratty","year":"2018","unstructured":"Khoyratty TE, Udalova IA. Diverse mechanisms of IRF5 action in inflammatory responses. Int J Biochem Cell Biol. 2018;99:38\u201342.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"1339_CR38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1189\/jlb.0910528","volume":"89","author":"JW Shui","year":"2011","unstructured":"Shui JW, Steinberg MW, Kronenberg M. Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling. J Leukoc Biol. 2011;89(4):517\u201323.","journal-title":"J Leukoc Biol"},{"issue":"7152","key":"1339_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature06005","volume":"448","author":"RJ Xavier","year":"2007","unstructured":"Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152):427\u201334.","journal-title":"Nature"},{"issue":"3","key":"1339_CR40","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1172\/JCI30587","volume":"117","author":"W Strober","year":"2007","unstructured":"Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007;117(3):514\u201321.","journal-title":"J Clin Invest"},{"issue":"1","key":"1339_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cell.2007.08.017","volume":"131","author":"WS Garrett","year":"2007","unstructured":"Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell. 2007;131(1):33\u201345.","journal-title":"Cell"},{"issue":"10","key":"1339_CR42","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"J Ni","year":"2017","unstructured":"Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14(10):573\u201384.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"27","key":"1339_CR43","doi-asserted-by":"publisher","first-page":"12204","DOI":"10.1073\/pnas.0909122107","volume":"107","author":"JL Round","year":"2010","unstructured":"Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010;107(27):12204\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1339_CR44","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s11926-012-0314-y","volume":"15","author":"N Yeoh","year":"2013","unstructured":"Yeoh N, Burton JP, Suppiah P, Reid G, Stebbings S. The role of the microbiome in rheumatic diseases. Curr Rheumatol Rep. 2013;15(3):314.","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"1339_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485\u201398.","journal-title":"Cell"},{"issue":"6","key":"1339_CR46","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.001","volume":"32","author":"HJ Wu","year":"2010","unstructured":"Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 2010;32(6):815\u201327.","journal-title":"Immunity"},{"issue":"3","key":"1339_CR47","first-page":"823","volume":"150","author":"P Parronchi","year":"1997","unstructured":"Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, et al. Type 1 T-helper cell predominance and Interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol. 1997;150(3):823\u201332.","journal-title":"Am J Pathol"},{"issue":"2","key":"1339_CR48","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","volume":"129","author":"F Heller","year":"2005","unstructured":"Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005;129(2):550\u201364.","journal-title":"Gastroenterology"},{"issue":"6937","key":"1339_CR49","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356\u201361.","journal-title":"Nature"},{"issue":"8","key":"1339_CR50","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1136\/gut.2008.163667","volume":"58","author":"S Brand","year":"2009","unstructured":"Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut. 2009;58(8):1152\u201367.","journal-title":"Gut"},{"key":"1339_CR51","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaut.2017.12.004","volume":"87","author":"A Ueno","year":"2018","unstructured":"Ueno A, Jeffery L, Kobayashi T, Hibi T, Ghosh S, Jijon H. Th17 plasticity and its relevance to inflammatory bowel disease. J Autoimmun. 2018;87:38\u201349.","journal-title":"J Autoimmun"},{"issue":"7","key":"1339_CR52","doi-asserted-by":"publisher","first-page":"e1700931","DOI":"10.1002\/mnfr.201700931","volume":"62","author":"D Bernardo","year":"2018","unstructured":"Bernardo D, Chaparro M, Gisbert JP. Human Intestinal Dendritic Cells in Inflammatory Bowel Diseases. Mol Nutr Food Res. 2018;62(7):e1700931 Mol Nutr Food Res.","journal-title":"Mol Nutr Food Res"},{"issue":"23","key":"1339_CR53","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205\u201319.","journal-title":"N Engl J Med"},{"issue":"6","key":"1339_CR54","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1365-2796.2008.01950.x","volume":"263","author":"KJ Maloy","year":"2008","unstructured":"Maloy KJ. The Interleukin-23 \/ Interleukin-17 axis in intestinal inflammation. J Intern Med. 2008;263(6):584\u201390.","journal-title":"J Intern Med"},{"issue":"5","key":"1339_CR55","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1172\/JCI25982","volume":"116","author":"B Selander","year":"2006","unstructured":"Selander B, Martensson U, Weintraub A, Holmstrom E, Matsushita M, Thiel S, et al. Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J Clin Invest. 2006;116(5):1425\u201334.","journal-title":"J Clin Invest"},{"issue":"7","key":"1339_CR56","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","volume":"11","author":"E Lubberts","year":"2015","unstructured":"Lubberts E. The IL-23-IL-17 axis in inflammatory arthritis. Nat Rev Rheumatol. 2015;11(7):415\u201329.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"1339_CR57","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/apt.13995","volume":"45","author":"PB Allen","year":"2017","unstructured":"Allen PB, Olivera P, Emery P, Moulin D, Jouzeau JY, Netter P, et al. Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis. Aliment Pharmacol Ther. 2017;45(8):1058\u201372.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"1339_CR58","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.rdc.2005.07.006","volume":"31","author":"CA Hitchon","year":"2005","unstructured":"Hitchon CA, Peschken CA, Shaikh S, El-Gabalawy HS. Early undifferentiated arthritis. Rheum Dis Clin N Am. 2005;31(4):605\u201326.","journal-title":"Rheum Dis Clin N Am"},{"issue":"9","key":"1339_CR59","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569\u201381.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1339_CR60","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/014107680409700903","volume":"97","author":"E Suresh","year":"2004","unstructured":"Suresh E. Diagnosis of early rheumatoid arthritis: what the non-specialist needs to know. J R Soc Med. 2004;97(9):421\u20134.","journal-title":"J R Soc Med"},{"key":"1339_CR61","doi-asserted-by":"crossref","unstructured":"Ledingham J, Snowden N, Ide Z. Diagnosis and early management of inflammatory arthritis. BMJ (Clinical research ed). 2017;358:j3248.","DOI":"10.1136\/bmj.j3248"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01339-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-020-01339-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01339-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T19:17:30Z","timestamp":1623871050000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-020-01339-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1339"],"URL":"https:\/\/doi.org\/10.1186\/s12876-020-01339-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.21860\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21860\/v2","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"16 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}